KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity
This study provides evidence that KIR2DS2 marks a population of NK cells primed for anticancer activity and indicates that KIR2DS2 is an attractive target for NK-based therapeutic strategies.PMID:35768150 | DOI:10.4049/jimmunol.2101139
Source: Journal of Immunology - Category: Allergy & Immunology Authors: Matthew D Blunt Andres Vallejo Pulido Jack G Fisher Lara V Graham Amber D P Doyle Rebecca Fulton Matthew J Carter Marta Polak Peter W M Johnson Mark S Cragg Francesco Forconi Salim I Khakoo Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Genetics | Hematology | Leukemia | Liver | Liver Transplant | Lymphoma | Rituxan | Study | Transplant Surgery | Transplants | Urology & Nephrology